Pierre-Antoine
Nocquet
a,
Raphaël
Hensienne
a,
Joanna
Wencel-Delord‡
a,
Eugénie
Laigre
a,
Khadidja
Sidelarbi
b,
Frédéric
Becq
b,
Caroline
Norez
b,
Damien
Hazelard
a and
Philippe
Compain
*a
aLaboratoire de Synthèse Organique et Molécules Bioactives (SYBIO), Université de Strasbourg/CNRS (UMR 7509), Ecole Européenne de Chimie, Polymères et Matériaux (ECPM), 25 rue Becquerel, 67087 Strasbourg, France. E-mail: philippe.compain@unistra.fr
bLaboratoire Signalisation et Transports Ioniques Membranaires (STIM), Université de Poitiers et CNRS (ERL7368), 1 rue Georges Bonnet, 86000 Poitiers, France
First published on 28th January 2016
A synthetic route to a new class of conformationally constrained iminosugars based on a 5-azaspiro[3.4]octane skeleton has been developed by way of Rh(II)-catalyzed C(sp3)–H amination. The pivotal stereocontrolled formation of the quaternary C–N bond by insertion into the C–H bonds of the cyclobutane ring was explored with a series of polyoxygenated substrates. In addition to anticipated regioselective issues induced by the high density of activated α-ethereal C–H bonds, this systematic study showed that cyclobutane C–H bonds were, in general, poorly reactive towards catalytic C–H amination. This was demonstrated inter alia by the unexpected formation of a oxathiazonane derivative, which constitutes a very rare example of the formation of a 9-membered ring by way of catalyzed C(sp3)–H amination. A complete stereocontrol could be however achieved by activating the key insertion position as an allylic C–H bond in combination with reducing the electron density at the undesired C–H insertion sites by using electron-withdrawing protecting groups. Preliminary biological evaluations of the synthesized spiro-iminosugars were performed, which led to the identification of a new class of correctors of the defective F508del-CFTR gating involved in cystic fibrosis.
In connection with our interest in biologically relevant glycomimetics,7 we recently described the synthesis of the first examples of conformationally constrained iminosugars 1–2 based on four-membered ring-containing spirocycles (Fig. 2).8
These compounds were designed as analogues of 1-deoxynojirimycin (DNJ, 3), a common motif found in many bioactive iminosugars, such as the antidiabetic Glyset™ or Zavesca™ (Gaucher disease, cystic fibrosis).9,10 In addition to exploring unfrequented regions of chemical and intellectual property spaces, we were interested in performing the first catalytic C–H amination of cyclobutanes11 to generate the pivotal C–N spiranic bond. An additional challenge was to design efficient strategies to secure high regioselectivity in polyoxygenated substrates with up to four contiguous reactive C–H bonds. Herein we wish to describe the full details of this synthetic study that led to unexpected regioselectivity and to a new class of bioactive iminosugars.
Sulfamic ester 7 was expected to be a promising reaction substrate in terms of regioselectivity since C–H insertion into a tertiary C–H bond to form a 6-membered cyclic sulfamidate is supposed to be highly favoured. Insertion into the α-ethereal C–H bonds at C1 or C3 to form a less favourable 7-membered ring could nevertheless not be ruled out. We first envisioned original iminosugars of type I since sulfamidates II could be direct precursors to 1-azaspiro[3.3]heptanes following a two-step protocol involving a ring-opening/ring-closing cascade.15 After the activation of the oxathiazinane ring by N-acylation, the desired azetidine ring was indeed expected to be obtained by a one-pot reaction with NaI followed by NaH. Compound 7 was obtained in 3 steps from 4 (Scheme 1). First attempts to protect the secondary alcohol in 4 with a benzyl group under classical basic conditions (NaH, BnBr) led to sluggish conversion. Better results were obtained for protection as a silyl ether and 5 could be eventually obtained in 80% yield. After the reduction of ester 5 with LAH, the corresponding alcohol 6 was reacted with sulfamoyl chloride and DMAP to afford sulfamic ester 7. Quite surprisingly, exposure of 7 to the standard C–H amination protocol using PhI(OAc)2, MgO and a catalytic amount of Rh2(OAc)4 did not lead to any expected C–H insertion products but instead afforded alcohol 8 in 32% yield. The structure of 8 was unambiguously determined by using a heteronuclear multiple-bond correlation (HMBC) between benzylic protons and C-2 (see the ESI† for the HMBC spectrum of 8). The highly regioselective deprotection of the benzyloxy group at C1 could be explained by the formation of a 9-membered cyclic sulfamidate (Scheme 1). C–H insertion into the activated methylene of the benzylic ether would generate a labile hemiaminal that could be readily hydrolysed during the work-up procedure to give 8. It is noteworthy that only one example of the formation of a 9-membered ring by way of intramolecular-catalyzed C–H amination has been reported so far in the literature.6c In the aforementioned study, the macrocyclic sulfamidate was nevertheless obtained in low yields (16%) from (Z)-hex-4-en-1-yl sulfamate, the major product being the corresponding expected oxathiazinane derivative.
The unexpected outcome of the C–H amination of 7 prompted us to adopt a different strategy since the regioselectivity observed showed quite clearly that C–H bonds in cyclobutane were poorly reactive. No C–H insertions were indeed observed either at C4 or at C1 or C3 despite the fact that tertiary C–H bonds and tertiary α-ethereal C–H bonds are known to be favoured towards Rh(II)-catalyzed C–H amination. These results are consistent with the significantly lower s-character of the exocyclic bonds on four-membered hydrocarbon rings.11b
Entry | Cat. (mol%) | Solvent | Reaction time (h) | R | 10 | 11b | 9c |
---|---|---|---|---|---|---|---|
a See the Experimental section for the experimental conditions. b Isolated yields. c Recovered after purification on a silica gel. d The reaction was performed at 60 °C. | |||||||
1 | Rh2(OAc)4 (5) | CH2Cl2 | 7 | Bn | — | 54% | 12% |
2 | Rh2(esp)2 (2) | CH2Cl2 | 7 | Bn | — | 61% | 18% |
3 | Rh2(tpa)4 (5) | CH2Cl2 | 15 | Bn | — | 46% | 31% |
4 | Rh2(esp)2 (2) | CH2Cl2 | 8 | Ac | — | — | 72% |
5 | Rh2(tpa)4 (10) | C6H6d | 8 | Ac | — | — | ∼10% |
A different tactic was designed to generate the desired C–N bond at C4, taking advantage of the C–H amination product 11a. The objective was to cleave the oxazolidinone ring to afford a hemiaminal function, as a masked ketone, and a secondary alcohol at C3 (compound 13) that may be converted into the corresponding carbamate to perform a second C–H amination reaction (Scheme 2).
After N-Boc protection, oxazolidinone 12 was reacted with cesium carbonate16 to provide alcohol 13 which was converted into the corresponding carbamate 14 in 51% yield for the three steps. Unfortunately, despite several attempts using typical rhodium-catalyzed conditions, no C–H amination product could be obtained from 14 and only the starting material was recovered in up to 52% yield.
Another strategy to avoid regioselectivity issues was to introduce the carbamate function on the carbon side chain at C4 (Scheme 3). Due to the strong bias of carbamates for 5-membered ring formation, C–H insertion was expected to occur exclusively at C4 from substrates 16. Three carbamates protected (Ac, TBS) or not at C3 were synthesized from alcohol 15.7a None of these compounds led to the desired azaspiranic products under typical Rh(II)-catalyzed C–H amination conditions. In each case, the starting material was the only compound that could be isolated by chromatography on a silica gel.
These results indicated that even in the absence of a strong electron-withdrawing group in the β-position, as in carbamate 9, the cyclobutane tertiary C–H bond was not reactive enough to undergo the C–H insertion process.
Combining C–H amination and RCM has two main advantages in terms of synthetic efficiency. First of all, the vinylic group introduced to direct the C–H insertion at C4 is directly involved in the construction of the second ring of our azaspiranic targets. Secondly, no additional steps are required to avoid the poisoning of the metathesis catalyst since the nitrogen atom is deactivated by an electron-withdrawing group.17 The feasibility of our strategy was first evaluated on a simplified cyclobutane derivative, carbamate 19 (Scheme 4). This compound was synthesized by carbamoylation of the readily available racemic alcohol 18 obtained in 2 steps from vinyl epoxide.18 Another advantage of using 19 as a model substrate is that it reproduces the same structural pattern found in VII – a trans-1-carbamoyl-2-vinylcyclobutane motif – but with minimal regioselectivity issues.
Encouragingly, treatment of 19 with 10 mol% of Rh(esp)2 or Rh2(oct)4 and stoichiometric amounts of PhI(OAc)2 and MgO in CH2Cl2 provided the expected C–H insertion product 20 in 41% yield (Table 2, entries 1 and 2). Increasing the amount of catalyst to 20 mol% or performing the reaction in refluxing dichloroethane (DCE) led to improved yields up to 58% (entries 3 and 4). Replacing PhI(OAc)2 with PhI(OPiv)2 did not increase the efficiency of the C–H insertion process (entry 5). The modest yields observed for the formation of cyclic carbamate 20 further confirmed the low reactivity of cyclobutane C–H bonds towards catalytic C–H amination.
Entry | Cat. (mol%) | Solvent | Reaction time (h) | T | 20b | 19c |
---|---|---|---|---|---|---|
a See the Experimental section for the experimental conditions. b Isolated yields. c Recovered after purification on a silica gel. d PhI(OPiv)2 was used instead of PhI(OAc)2. | ||||||
1 | Rh2(esp)2 (10) | CH2Cl2 | 17 | Δ | 41% | 39% |
2 | Rh2(oct)4 (10) | CH2Cl2 | 32 | Δ | 41% | 6% |
3 | Rh2(esp)2 (20) | CH2Cl2 | 55 | Δ | 52% | 19% |
4 | Rh2(esp)2 (15) | DCE | 43 | Δ | 58% | 16% |
5d | Rh2(esp)2 (15) | CH2Cl2 | 32 | Δ | 47% | 22% |
The C–H allylic bonds also provide an opportunity for performing C–H amination via π-allyl species. To apply the methodology recently developed by the group of White based on electrophilic Pd(II)/sulfoxide catalysis,19 alcohol 18 was converted into the corresponding N-tosylcarbamate 21 by treatment with TsNCO (Scheme 5). Under standard allylic C–H amination conditions using phenyl bis-sulfoxide/Pd(OAc)2 and a stoichiometric amount of phenyl-benzoquinone (PhBQ), the desired N-tosylcarbamate 22 was obtained in only 9% yield (15% based on the recovered starting materials). In addition, 22 is obtained as a mixture with PhBQ since the two compounds are difficult to separate by flash chromatography. No improvement was obtained when the reaction was performed under an oxygen atmosphere or in the presence of additives including AcOH,20 Na2S2O8, PhI(OAc)2 or Ag2CO3. To the best of our knowledge, this result is a very rare example of a C–H amination of a tertiary allylic C–H bond using White's methodology.21
Despite the modest yields observed in the model study, carbamate 23a was synthesized by carbamoylation of alcohol 177a,8 and subjected to a Rh(II)-catalyzed C–H amination (Table 3, entry 1). Disappointingly, in contrast to previous results obtained with pyran or acyclic substrates,12 the regioselectivity of insertion was strongly in favor of the methine group adjacent to the oxygen atom over the allylic C–H bond at C4. After an extensive study, the best results in terms of yields and regioselectivity were obtained when carbamate 23a was treated with 20 mol% of Rh2(esp)2 and stoichiometric amounts of PhI(OAc)2 and MgO in refluxing CH2Cl2.8 These reaction conditions led to a complete conversion of 23a and to the desired allylic C–H insertion 24a but in only 17% yield, carbamate 25a being still the major product (56% yield). To overcome this unexpected obstacle, we designed a strategy to strongly disfavour the formation of the unwanted regioisomer 25. Our objective was to reduce the electron density of the α-oxygenated C–H bond at C2 by using electron-withdrawing protecting groups instead of benzyloxy groups. However, such a tactic may be seen as a double-edged sword since the presence of three electron-withdrawing groups around the cyclobutane ring may also reduce the reactivity of the C–H bond at C4. Acetate and benzoate esters were firstly selected as hydroxyl-protecting groups.
Entry | Rh2(esp)2 (mol%) | Reaction time (h) | R | δ(H2) ppmb | δ(H4) ppmb | 24c | 25c | 23d |
---|---|---|---|---|---|---|---|---|
a See the Experimental section for the experimental conditions. b From the 1H NMR spectrum of compounds 23 recorded in CDCl3. c Isolated yields. d Recovered after purification on a silica gel. e DCE was used instead of CH2Cl2. | ||||||||
1 | 20 | 27 | Bn | 3.95 | 2.48 | 17% | 56% | — |
2 | 15 | 8 | Ac | 5.09 | 2.65 | 26% | — | 10% |
3 | 15 | 24 | Ac | 5.09 | 2.65 | 31% | — | — |
4 | 20 | 23 | p-MeOBz | 5.49 | 2.85 | 40% | — | 12% |
5 | 20 | 23 | Bz | 5.53 | 2.90 | 40% | — | 10% |
6e | 25 | 40 | Bz | 5.53 | 2.90 | 32% | — | 23% |
To fine tune the electronic environment around the reactive cyclobutane C–H bond, para-methoxybenzoate ester 23d was also prepared as a close analogue of substrate 23c. The esters 23b, 23c and 23d were synthesized in 2 steps from carbamate 23a by deprotection of the benzyl group followed by treatment with Ac2O, BzCl or para-methoxybenzoyl chloride (p-MeOBzCl) in the presence of pyridine (Scheme 6).
To our delight, the electron-withdrawing group strategy reached its goal, allowing complete regioselectivity towards the desired C–H insertion products 24 (Table 3, entries 2–6). As with substrate 23a, the reaction time has to be relatively long (∼24 h) to ensure total conversion of the starting material (entries 2 and 3) and acetate-protected carbamate 24b was obtained in up to 31% yield. The use of the more electron-withdrawing benzoate group was found to increase the yield by ∼20% (entries 3 and 5). In contrast to the results obtained in the model study (Table 2), reactions performed in DCE do not increase the yield of the process (entry 6). The addition of an electron-donating group to the benzoate phenyl ring had no impact on the yield of the C–H amination reaction and carbamate 24d was obtained in 40% yield (entry 4). As shown by the 1H NMR of compounds 23 (Table 3), the signals of H2 shifted downfield upon increasing the electron-withdrawing ability of the hydroxyl protecting groups, an observation consistent with a decrease of electron density around H2. The H2 chemical shifts correlated nicely with the yields of carbamates 24 and the level of regiocontrol achieved. As suggested by the downfield shifts of H4 protons from 2.48 ppm (R = Bn) to 2.90 ppm (R = Bz), the addition of two electron-withdrawing groups impacted also the electron density at C4 and thus the efficiency of the desired C–H amination reaction. Despite the modest yields observed, the electron-withdrawing group strategy was nonetheless efficient if one considers the complete regiocontrol achieved and the yields obtained with the related carbamate 19, a substrate with minimal regioselectivity issues. In addition, the yields of the C–H amination reaction provided the azaspiranic intermediate 24c in quantities sufficient to complete the synthesis of the targeted iminosugars 1–2. To pursue our synthetic goal, we took advantage of the readily available model substrate 26 obtained by N-allylation of 20 to evaluate the key RCM step. Pleasingly, the highly constrained cyclobutane-containing tricycle 27 was obtained in 94% yield using 5 mol% Grubbs II catalyst in refluxing CH2Cl2 (Scheme 7). This result provides a further example of the powerfulness of the RCM process considering the large additional ring strain generated by the 5-membered ring closure.
The same process was applied to carbamate 24c with a similar efficiency for the RCM step (89% yield) to provide the 5-azaspiro[3.4]octane skeleton of our targets. The spiranic iminosugars 1–2 were then obtained in 2 or 3 steps from the common intermediate 28 thus generated (Scheme 8).8
In our previous study on Gaucher disease, a rare genetic disorder caused by the deficiency of β-glucocerebrosidase (GCase), we identified α-1-C-nonyl-iminoxylitol (29) as a promising lead for a pharmacological chaperone therapy (Fig. 6).25 This therapeutic strategy is based on the use of competitive inhibitors capable of enhancing GCase residual hydrolytic activity at sub-inhibitory concentrations.26,27 Reversible competitive inhibitors are indeed believed to modify and/or stabilize the three-dimensional structure of the deficient but still catalytically active glycosidase, preventing its premature degradation by the endoplasmic reticulum quality-control system before trafficking to lysosomes.27 α-1-C-Nonyl-iminoxylitol (29) was found to be a very specific nanomolar inhibitor of GCase.25 It was hypothesized that the qualitative leap in inhibitory potency between 29 and 30,25 the corresponding analogue in the D-gluco series, was due to a piperidine ring inversion from a classical 4C1(D) to a 1C4(D) conformation in which all hydroxyl groups are axial and the alkyl chain is equatorial.25,26,28
In a preliminary study, we evaluate whether further improvement of the activity might be gained for structures of type III that may be considered constrained mimetics of iminosugar 29 with the hydroxyl groups in pseudo axial orientation. Considering that the presence of an alkyl chain is important for GCase inhibitory activity but cytotoxicity may be associated with long alkyl chain iminosugar derivatives, first preliminary inhibitory assays were performed with spiro-iminosugar 2b (Fig. 6). This compound was found to display weak inhibitory activity (IC50 > 100 μM) and showed no significant improvement in the inhibition of GCase relative to the corresponding analogues in the D-gluco series, α-1-C-butyl DNJ (31)29 and N-butyl DNJ (Zavesca™).
R f 0.26 (EtOAc/petroleum ether, 1:19), [α]20D +0.5 (c 1.0, CHCl3), IR (film) 1733, 1097, 835 cm−1, 1H NMR (400 MHz, CDCl3) δ 7.41–7.28 (m, 10H, Ph), 4.66 (d, J = 11.7 Hz, 1H, CH2Ph), 4.61 (d, J = 11.7 Hz, 1H, CH2Ph), 4.56 (s, 2H, CH2Ph), 4.16 (q, J = 7.1 Hz, 2H, CH2CH3), 3.83 (m, 1H, H-2), 3.65 (m, 1H, H-1 or H-3), 3.49 (m, 1H, H-1 or H-3), 2.57 (dd, J = 15.0, 5.9 Hz, 1H, H-1′a), 2.50 (dd, J = 14.9, 6.9 Hz, 1H, H-1′b), 2.17 (m, 1H, H-4), 1.28 (t, J = 7.2 Hz, 3H, CH2CH3), 0.95 (s, 9H, C(CH3)3), 0.14 (s, 3H, SiCH3), 0.12 (s, 3H, SiCH3), 13C NMR (100 MHz, CDCl3) δ 171.7 (CO), 138.4 (Cq-Ar), 138.2 (Cq-Ar), 128.42 (2 CH-Ar), 128.40 (2 CH-Ar), 127.8 (4 CH-Ar), 127.70 (CH-Ar), 127.67 (CH-Ar), 86.0 (C-2), 77.3 (C-1 or C-3), 71.6 (2 CH2Ph), 71.1 (C-1 or C-3), 60.5 (CH2CH3), 41.2 (C-4), 36.3 (C-1′), 25.8 (C(CH3)3), 18.0 (C(CH3)3), 14.3 (CH2CH3), −4.5 (SiCH3), −4.6 (SiCH3), HRMS (ESI) m/z 507.250 ([M + Na]+, calcd for C28H40O5SiNa: 507.254).
R f 0.51 (EtOAc/petroleum ether, 1:3), [α]20D −5 (c 1.0, CHCl3), IR (film) 3449, 1061, 836 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.40–7.27 (m, 10H, Ph), 4.63 (d, J = 11.6 Hz, 1H, CH2Ph), 4.61–4.54 (m, 2H, CH2Ph), 4.52 (d, J = 11.6 Hz, 1H, CH2Ph), 3.80 (t, J = 5.7 Hz, 1H, H-2), 3.67 (m, 2H, H-2′), 3.53 (m, 1H, H-1 or H-3), 3.36 (m, 1H, H-1 or H-3), 2.50 (t, J = 6.6 Hz, 1H, OH), 1.86–1.68 (m, 3H, H-4, H-1′), 0.90 (s, 9H, C(CH3)3), 0.11 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), 13C NMR (75 MHz, CDCl3) δ 138.1 (Cq-Ar), 137.9 (Cq-Ar), 128.6 (2 CH-Ar), 128.5 (2 CH-Ar), 128.0 (3 CH-Ar), 127.9 (2 CH-Ar), 127.8 (CH-Ar), 86.0 (C-2), 77.8 (C-1 or C-3), 71.9 (C-1 or C-3), 71.8 (CH2Ph), 71.7 (CH2Ph), 61.9 (C-2′), 42.7 (C-4), 34.9 (C-1′), 25.8 (C(CH3)3), 17.9 (C(CH3)3), −4.4 (SiCH3), −4.5 (SiCH3), HRMS (ESI) m/z 465.241 ([M + Na]+, calcd For C26H38O4SiNa: 465.243).
IR (neat) 1374, 1174 cm−1.
DMAP (91 mg, 0.75 mmol, 2 equiv.) followed by ClSO2NH2 (65 mg, 0.56 mmol, 1.5 equiv.) were added to a solution of 6 (165 mg, 0.37 mmol, 1 equiv.) in CH2Cl2 (5.8 mL). After 2 h of stirring, a second portion of DMAP (91 mg, 0.75 mmol, 2 equiv.) followed by ClSO2NH2 (65 mg, 0.56 mmol, 1.5 equiv.) were added. The solution was stirred for 15 h. Water (a few drops) was added and the solution was filtered. The organic layer was dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was purified by flash chromatography (EtOAc/petroleum ether, 1:5 to 1:1) to afford 7 (130 mg, 67%) as a colorless oil.
R f 0.42 (EtOAc/petroleum ether, 1:3), [α]20D +5 (c 0.9, MeOH), IR (film) 3355, 1359 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.41–7.27 (m, 10H, Ph), 4.75 (s, 2H, NH2), 4.65 (d, J = 11.7 Hz, 1H, CH2Ph), 4.60–4.52 (m, 2H, CH2Ph), 4.48 (d, J = 11.2 Hz, 1H, CH2Ph), 4.22 (m, 2H, H-2′), 3.79 (t, J = 5.6 Hz, 1H, H-2), 3.53 (m, 1H, H-1 or H-3), 3.39 (m, 1H, H-1 or H-3), 2.07 (m, 1H, H-4), 1.84 (m, 2H, H-1′), 0.91 (s, 9H, C(CH3)3), 0.11 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), 13C NMR (75 MHz, CDCl3) δ 137.9 (Cq-Ar), 137.5 (Cq-Ar), 128.8 (2 CH-Ar), 128.6 (2 CH-Ar), 128.4 (2 CH-Ar), 128.3 (CH-Ar), 128.0 (3 CH-Ar), 86.3 (C-2), 77.6 (C-1 or C-3), 72.3 (C-1 or C-3), 71.79 (CH2Ph), 71.76 (CH2Ph), 69.6 (C-2′), 41.1 (C-4), 31.6 (C-1′), 25.9 (C(CH3)3), 18.0 (C(CH3)3), −4.2 (SiCH3), −4.5 (SiCH3), HRMS (ESI) m/z 544.212 ([M + Na]+, calcd for C26H39NO6SSiNa: 544.216).
R f 0.25 (EtOAc/petroleum ether, 2:1), [α]20D −8 (c 1.0, MeOH), IR (neat) 3386, 1385 cm−1, 1H NMR (300 MHz, CD3OD) δ 7.40–7.22 (m, 5H, Ph), 4.69 (d, J = 11.7 Hz, 1H, CH2Ph), 4.57 (d, J = 11.7 Hz, 1H, CH2Ph), 4.20 (t, J = 6.9 Hz, 2H, H-2′), 3.60 (t, J = 6.1 Hz, 1H, H2), 3.48 (m, 1H, H-1 or H-3), 3.40 (m, 1H, H-1 or H-3), 2.12–1.87 (m, 2H, H-1′), 1.66 (m, 1H, H-4), 0.90 (s, 9H, C(CH3)3), 0.10 (s, 6H, 2 SiCH3), 13C NMR (75 MHz, CD3OD) δ 139.6 (Cq-Ar), 129.5 (2 CH-Ar), 129.0 (2 CH-Ar), 128.8 (CH-Ar), 88.7 (C-2), 72.60 (C-1 or C-3), 72.57 (C-1 or C-3), 72.3 (CH2Ph), 69.2 (C-2′), 44.0 (C-4), 32.5 (C-1′), 26.4 (C(CH3)3), 18.9 (C(CH3)3), −4.2 (SiCH3), −4.3 (SiCH3), HRMS (ESI) m/z 454.169 ([M + Na]+, calcd for C19H33NO6SSiNa: 454.169).
R f 0.45 (EtOAc/petroleum ether, 1:2), [α]20D = −12 (c 1.0, MeOH), IR (neat) 3440, 1723, 1666, cm−1, 1H NMR (300 MHz, CDCl3) δ 7.40–7.23 (m, 10H, Ph), 4.64–4.46 (m, 7H, 2 CH2Ph, NH2, H-3), 4.12 (q, J = 7.2 Hz, 2H, CH2CH3), 3.94 (m, 1H, H-2), 3.55 (m, 1H, H-1), 2.65 (dd, J = 16.1, 7.4 Hz, 1H, H-1′a), 2.56 (dd, J = 16.1, 6.2 Hz, 1H, H-1′b), 2.27 (m, 1H, H-4), 1.24 (t, J = 7.1 Hz, 3H, CH2CH3), 13C NMR (75 MHz, MeOD) δ 173.4 (CO), 158.8 (NCO), 139.4 (Cq-Ar), 139.2 (Cq-Ar), 129.38 (2 CH-Ar), 129.35 (2 CH-Ar), 129.1 (2 CH-Ar), 128.9 (2 CH-Ar), 128.8 (2 CH-Ar), 83.8 (C-2), 77.9 (C-1), 73.2 (C-3), 72.7 (CH2Ph), 72.3 (CH2Ph), 61.7 (CH2CH3), 40.4 (C-4), 36.8 (C-1′), 14.5 (CH2CH3), HRMS (ESI) m/z 436.172 ([M + Na]+, calcd for C23H27NO6Na: 436.173).
R f 0.31 (silica gel, EtOAc/petroleum ether, 2:1), [α]20D = +2 (c 1.0, CHCl3), IR (film) 3474, 1725, 1225 cm−1, 1H NMR (300 MHz, CDCl3) δ 5.09 (t, J = 6.3 Hz, 1H, H-2), 5.02 (br s, 2H, NH2), 4.68 (dd, J = 7.7, 6.3 Hz, 1H, H-1 or H-3), 4.61 (dd, J = 7.8, 6.3 Hz, 1H, H-1 or H-3), 4.08 (q, J = 7.2 Hz, 2H, CH2CH3), 2.72 (m, 2H, H-1′), 2.38 (m, 1H, H-4), 2.04 (s, 3H, CH3), 2.03 (s, 3H, CH3), 1.21 (t, J = 7.2 Hz, 3H, CH2CH3), 13C NMR (75 MHz, CDCl3) δ 171.4 (CO), 170.4 (CO), 170.0 (CO), 155.8 (NCO), 74.4 (C-2), 70.7 (C-1 or C-3), 70.0 (C-1 or C-3), 60.7 (CH2CH3), 38.9 (C-4), 35.4 (C-1′), 20.8 (2 CH3), 14.2 (CH2CH3), HRMS (ESI) m/z 340.099 ([M + Na]+, calcd for C13H19NO8Na: 340.100).
R f 0.22 (EtOAc/petroleum ether, 1:2), [α]20D −25 (c 1.0, CHCl3), IR (film) 3286, 1757, 1730 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.40–7.24 (m, 10H, Ph), 5.61 (s, 1H, NH), 4.62–4.48 (m, 3H, CH2Ph), 4.48–4.41 (m, 2H, CH2Ph, H-3), 4.14 (q, J = 7.1 Hz, 2H, CH2CH3), 4.00 (dd, J = 6.9, 1.1 Hz, 1H, H-1), 2.56 (dd, J = 16.0, 5.9 Hz, 1H, H-1′a), 2.44 (dd, J = 16.0, 7.4 Hz, 1H, H-1′b), 2.33 (m, 1H, H-4), 1.24 (t, J = 7.1 Hz, 3H, CH2CH3), 13C NMR (75 MHz, CDCl3) δ 170.9 (CO), 158.7 (NCO), 137.4 (Cq-Ar), 136.9 (Cq-Ar), 128.69 (2 CH-Ar), 128.66 (2 CH-Ar), 128.4 (CH-Ar), 128.3 (2 CH-Ar), 128.2 (CH-Ar), 127.8 (2 CH-Ar), 91.7 (C-2), 80.8 (C-1 or C-3), 75.8 (C-1 or C-3), 72.8 (CH2Ph), 65.8 (CH2Ph), 61.0 (CH2CH3), 42.3 (C-4), 34.7 (C-1′), 14.3 (CH2CH3), HRMS (ESI) m/z 434.154 ([M + Na]+, calcd for C23H25NO6Na: 434.157).
R f 0.56 (EtOAc/petroleum ether, 1:2), [α]20D −42 (c 1.0, CHCl3), IR (film) 1816, 1736 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.40–7.24 (m, 10H, Ph), 4.78 (d, J = 12.1 Hz, 1H, CH2Ph), 4.59 (d, J = 11.2 Hz, 1H, CH2Ph), 4.53 (d, J = 11.9 Hz, 1H, CH2Ph), 4.47 (d, J = 11.2 Hz, 1H, CH2Ph), 4.36 (m, 1H, H-1 or H-3), 4.10 (q, J = 7.1 Hz, 2H, CH2CH3), 4.09–4.02 (m, 1H, H-1 or H-3), 2.50 (m, 1H, H-1′a), 2.41–2.27 (m, 2H, H-1′b, H-4), 1.47 (s, 9H, C(CH3)3), 1.22 (t, J = 7.2 Hz, 3H, CH2CH3), 13C NMR (75 MHz, CDCl3) δ 170.7 (CO), 152.8 (NCO), 149.1 (NCO), 137.7 (Cq-Ar), 136.4 (Cq-Ar), 128.7 (2 CH-Ar), 128.5 (2 CH-Ar), 128.3 (CH-Ar), 128.0 (3 CH-Ar), 127.8 (2 CH-Ar), 94.3 (C-2), 84.2 (C(CH3)3), 80.2 (C-1 or C-3), 73.1 (CH2Ph), 72.8 (C-1 or C-3), 66.4 (CH2Ph), 61.1 (CH2CH3), 42.3 (C-4), 34.5 (C-1′), 28.0 (C(CH3)3), 14.3 (CH2CH3), HRMS (ESI) m/z 534.204 ([M + Na]+, calcd for C28H33NO8Na: 534.204).
R f 0.49 (EtOAc/petroleum ether, 1:2), [α]20D −25 (c 1.0, CHCl3), IR (film) 3417, 1732, 1483 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.40–7.23 (m, 10H, Ph), 5.98 (br s, 1H, NH), 4.61 (d, J = 11.7 Hz, 1H, CH2Ph), 4.56 (d, J = 11.9 Hz, 1H, CH2Ph), 4.55 (d, J = 11.4 Hz, 1H, CH2Ph), 4.43 (d, J = 11.6 Hz, 1H, CH2Ph), 4.13 (q, J = 7.2 Hz, 2H, CH2CH3), 3.91 (d, J = 7.8 Hz, 1H, H-1 or H-3), 3.56 (d, J = 7.8 Hz, 1H, H-1 or H-3), 2.51 (dd, J = 6.9, 2.3 Hz, 2H, H-1′), 2.24 (m, 1H, H-4), 1.45 (s, 9H, C(CH3)3), 1.24 (t, J = 7.1 Hz, 3H, CH2CH3), 13C NMR (75 MHz, CDCl3) δ 172.3 (CO), 156.3 (NCO), 138.1 (Cq-Ar), 137.6 (Cq-Ar), 128.6 (2 CH-Ar), 128.5 (2 CH-Ar), 128.21 (CH-Ar), 128.17 (2 CH-Ar), 127.9 (2 CH-Ar), 127.7 (CH-Ar), 89.3 (C(CH3)3 or C-2), 80.9 (C(CH3)3 or C-2), 77.7 (C-1 or C-3), 73.6 (C-1 or C-3), 72.6 (CH2Ph), 65.7 (CH2Ph), 60.8 (CH2CH3), 41.8 (C-4), 36.2 (C-1′), 28.3 (C(CH3)3), 14.3 (CH2CH3), HRMS (ESI) m/z 508.223 ([M + Na]+, calcd for C27H35NO7Na: 508.231).
R f 0.13 (silica gel, EtOAc/petroleum ether, 1:2), [α]20D −33 (c 1.0, CHCl3), IR (film) 3423, 2931, 1724, 1158 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.37–7.17 (m, 10H, Ph), 5.69 (br s, 1H, NHBoc), 4.87 (br s, 2H, NH2), 4.78 (d, J = 7.6 Hz, 1H, H-1 or H-3), 4.65 (m, 1H, CH2Ph), 4.56–4.37 (m, 3H, CH2Ph), 4.05 (q, J = 7.1 Hz, 2H, CH2CH3), 3.58 (d, J = 7.5 Hz, 1H, H-1 or H-3), 2.59–2.44 (m, 2H, H-1′), 2.38 (m, 1H, H-4), 1.42 (s, 9H, C(CH3)3), 1.18 (t, J = 7.2 Hz, 3H, CH2CH3), 13C NMR (100 MHz, CDCl3) δ 171.5 (CO), 155.3 (2 NCO), 138.2 (Cq-Ar), 137.7 (Cq-Ar), 128.6 (2 CH-Ar), 128.4 (3 CH-Ar), 128.1 (3 CH-Ar), 127.9 (CH-Ar), 127.6 (CH-Ar), 89.3 (C-2), 79.8 (C(CH3)3), 78.5 (C-1 or C-3), 73.4 (C-1 or C-3), 73.0 (CH2Ph), 65.9 (CH2Ph), 60.8 (CH2CH3), 40.6 (C-4), 36.0 (C-1′), 28.3 (C(CH3)3), 14.3 (CH2CH3), HRMS (ESI) m/z 551.230 ([M + Na]+, calcd for C28H36N2O8Na: 551.236).
R f 0.41 (EtOAc/petroleum ether, 1:2), [α]20D −2 (c 1.0, CHCl3), IR (film) 3353, 1720, 1331 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.30–7.16 (m, 10H, Ph), 4.64 (br s, 2H, NH2), 4.55 (d, J = 11.7 Hz, 1H, CH2Ph), 4.49 (d, J = 11.7 Hz, 1H, CH2Ph), 4.48 (d, J = 11.9 Hz, 1H, CH2Ph), 4.43 (d, J = 11.7 Hz, 1H, CH2Ph), 4.09 (m, 2H, H-1′), 3.76 (t, J = 5.6 Hz, 1H, H-2), 3.59 (m, 1H, H-1 or H-3), 3.41 (m, 1H, H-1 or H-3), 1.93 (m, 1H, H-4), 0.82 (s, 9H, C(CH3)3), 0.02 (s, 3H, CH3), 0.00 (s, 3H, CH3), 13C NMR (75 MHz, CDCl3) δ 156.8 (NCO), 138.2 (Cq-Ar), 138.1 (Cq-Ar), 128.54 (2 CH-Ar), 128.52 (2 CH-Ar), 127.92 (2 CH-Ar), 127.86 (4 CH-Ar), 86.0 (C-2), 74.7 (C-1 or C-3), 71.74 (CH2Ph), 71.73 (CH2Ph), 68.4 (C-1 or C-3), 63.9 (C-1′), 44.3 (C-4), 25.8 (C(CH3)3), 18.0 (C(CH3)3), −4.5 (CH3), −4.7 (CH3), HRMS (ESI) m/z 494.237 ([M + Na]+, calcd for C26H37NO5SiNa: 494.233).
R f 0.16 (MeOH/CH2Cl2, 5:95), [α]20D −4 (c 1.0, CHCl3), IR (film) 3351, 1705, 1331 cm−1, 1H NMR (300 MHz, CD3OD) δ 7.39–7.23 (m, 10H, Ph), 4.65 (d, J = 11.7 Hz, 1H, CH2Ph), 4.57 (d, J = 11.7 Hz, 1H, CH2Ph), 4.56 (d, J = 11.7 Hz, 1H, CH2Ph), 4.51 (d, J = 11.9 Hz, 1H, CH2Ph), 4.12 (d, J = 5.1 Hz, 2H, H-1′), 3.78 (t, J = 5.8 Hz, 1H, H-2), 3.57 (m, 1H, H-1 or H-3), 3.49 (m, 1H, H-1 or H-3), 1.92 (m, 1H, H-4), 13C NMR (75 MHz, CD3OD) δ 159.8 (NCO), 139.6 (Cq-Ar), 139.4 (Cq-Ar), 129.36 (2 CH-Ar), 129.34 (2 CH-Ar), 129.0 (4 CH-Ar), 128.74 (CH-Ar), 128.70 (CH-Ar), 86.6 (C-2), 75.7 (C-1 or C-3), 72.6 (CH2Ph), 72.2 (CH2Ph), 68.9 (C-1 or C-3), 64.4 (C-1′), 45.5 (C-4), HRMS (ESI) m/z 380.145 ([M + Na]+, calcd for C20H23NO5Na: 380.147).
R f 0.17 (EtOAc/petroleum ether, 1:1), [α]20D = −5 (c 1.0, CHCl3), IR (film) 3363, 2923, 1738, 1238 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.41–7.24 (m, 10H, Ph), 4.71 (br s, 2H, NH2), 4.63–4.55 (m, 4H, H-1 or H-3, CH2Ph), 4.52 (d, J = 11.7 Hz, 1H, CH2Ph), 4.28 (dd, J = 11.4, 4.5 Hz, 1H, H-1′a), 4.18 (dd, J = 11.4, 5.5 Hz, 1H, H-1′b), 3.97 (t, J = 5.8 Hz, 1H, H-2), 3.66 (m, 1H, H-1 or H-3), 2.13 (m, 1H, H-4), 2.03 (s, 3H, CH3), 13C NMR (75 MHz, CDCl3) δ 170.3 (CO), 156.7 (NCO), 138.0 (Cq-Ar), 137.8 (Cq-Ar), 128.59 (2 CH-Ar), 128.57 (2 CH-Ar), 128.1 (2 CH-Ar), 128.01 (CH-Ar), 127.98 (CH-Ar), 127.9 (2 CH-Ar), 82.7 (C-2), 74.7 (C-1 or C-3), 72.0 (CH2Ph), 71.8 (CH2Ph), 69.2 (C-1 or C-3), 63.6 (C-1′), 42.6 (C-4), 21.0 (CH3), HRMS (ESI) m/z 422.153 ([M + Na]+, calcd for C22H25NO6Na: 422.157).
R f 0.44 (EtOAc/toluene, 2:8), IR (neat) 3354, 1715, cm−1, 1H NMR (400 MHz, CDCl3) δ 7.37–7.27 (m, 2H, Ph), 7.24–7.14 (m, 3H, Ph), 5.99 (ddd, J = 17.2 Hz, 10.3, 6.6 Hz, 1H, H-1′), 5.15 (d, J = 8.0 Hz, 1H, H-3), 5.08 (dt, J = 17.5, 1.5 Hz, 1H, H-2′a), 5.02 (dt, J = 10.4, 1.4 Hz, 1H, H-2′b), 4.92 (br s, 2H, NH2), 3.14–3.01 (m, 1H, H-4), 2.20 (t, J = 10.4 Hz, 1H, H-1a), 1.84 (t, J = 10.3 Hz, 1H, H-1b), 1.46 (s, 3H, CH3), 13C NMR (100 MHz, CDCl3) δ 156.3 (NCO), 149.8 (Cq-Ar), 139.0 (C-1′), 128.5 (2 CH-Ar), 126.0 (CH-Ar), 125.1 (2 CH-Ar), 114.6 (C-2′), 78.0 (C-3), 45.7 (C-2), 42.7 (C-4), 32.8 (C-1), 24.5 (CH3), HRMS (ESI) m/z 254.116 ([M + Na]+, calcd for C14H17NO2Na: 254.115).
R f 0.27 (EtOAc/ toluene, 2:8), IR (film) 3281, 1750 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.44–7.30 (m, 2H, Ph), 7.29–7.15 (m, 3H, Ph), 6.49 (br s, 1H, NH), 5.90 (dd, J = 17.2 Hz, 10.6 Hz, 1H, H-1′), 5.26 (d, J = 17.5 Hz, 1H, H-2′a), 5.21 (d, J = 10.7 Hz, 1H, H-2′b), 4.97 (s, 1H, H-3), 2.81 (d, J = 12.9 Hz, 1H, H-1a), 2.48 (d, J = 12.9 Hz, 1H, H-1b), 1.55 (s, 3H, CH3), 13C NMR (75 MHz, CDCl3) δ 160.8 (NCO), 148.3 (Cq-Ar), 137.8 (C-1′), 128.9 (2 CH-Ar), 126.5 (CH-Ar), 125.3 (2 CH-Ar), 116.3 (C-2′), 86.5 (C-3), 59.7 (C-4), 45.5 (C-2), 43.6 (C-1), 26.3 (CH3), HRMS (ESI) m/z 252.100 ([M + Na]+, calcd for C14H15NO2Na: 252.099).
R f 0.25 (EtOAc/petroleum ether, 2:8), IR (film) 3241, 1740 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.95 (d, J = 8.1 Hz, 2H, Ar), 7.36 (d, J = 8.2 Hz, 2H, Ar), 7.30–7.21 (m, 2H, Ar), 7.21–7.12 (m, 1H, Ar), 7.09–7.01 (m, 2H, Ar), 5.96–5.80 (m, 1H, H-1′), 5.04 (d, J = 7.9 Hz, 1H, H-3), 5.00–4.90 (m, 2H, H-2′), 3.08–2.92 (m, 1H, H-4), 2.46 (s, 3H, CH3-Ph), 2.19 (t, J = 10.3 Hz, 1H, H-1a), 1.82 (t, J = 10.3 Hz, 1H, H-1b), 1.38 (s, 3H, CH3-Ph), 13C NMR (100 MHz, CDCl3) δ 149.7 (NCO or Cq-Ar), 148.9 (NCO or Cq-Ar), 145.2 (NCO or Cq-Ar) 138.2 (C-1′), 135.8 (Cq-Ar), 129.8 (2 CH-Ar), 128.6 (2 CH-Ar), 128.4 (2 CH-Ar), 126.2 (CH-Ar), 124.9 (2 CH-Ar), 115.2 (C-2′), 80.4 (C-3), 45.6 (C-2), 42.3 (C-4), 32.5 (C-1), 24.6 (CH3), 21.8 (CH3), HRMS (ESI) m/z 408.126 ([M + Na]+, calcd for C21H23NO4SNa: 408.124).
R f 0.5 (EtOAc/petroleum ether, 1:9) IR (film) 1785 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.98 (d, J = 8.3 Hz, 2H, Ar), 7.40–7.30 (m, 4H, Ar), 7.25–7.20 (m, 1H, Ar), 7.17 (d, J = 7.7 Hz, 2H, Ar), 6.04 (dd, J = 17.3, 10.6 Hz, 1H, H-1′), 5.39 (d, J = 10.2 Hz, 1H, H-2a′), 5.36 (d, J = 16.8 Hz, 1H, H-2a′), 4.87 (s, 1H, H-3), 3.00 (s, 2H, H-1), 2.45 (s, 3H, CH3-Ph), 1.47 (s, 3H, CH3-Ph), 13C NMR (100 MHz, CDCl3) δ 153.3 (NCO), 147.6 (Cq-Ar), 145.7 (Cq-Ar), 135.8 (C-1′), 135.6 (Cq-Ar), 130.3 (2 CH-Ar), 129.05 (2 CH-Ar), 129.0 (2 CH-Ar), 126.8 (CH-Ar), 125.1 (2 CH-Ar), 119.0 (C-2′), 84.1 (C-3), 65.6 (C-4), 45.3 (C-2), 40.9 (C-1), 26.3 (CH3), 21.9 (CH3), HRMS (m/z 406.109 ([M + Na]+, calcd for C21H21NO4SNa: 406.108).
R f 0.46 (EtOAc/petroleum ether, 1:2), [α]20D +3 (c 1.0, CHCl3), IR (film) 3354, 1718, 1326, 1087 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.41–7.20 (m, 10H, Ph), 5.95 (ddd, J = 17.3, 10.2, 7.2 Hz, 1H, H-1′), 5.19 (d, J = 17.3 Hz, 1H, H-2′a), 5.09 (d, J = 10.2 Hz, 1H, H-2′b), 4.72–4.42 (m, 7H, 2 CH2Ph, NH2, H-1 or H-3), 3.95 (t, J = 5.9 Hz, 1H, H-2), 3.60 (m, 1H, H-1 or H-3), 2.48 (q, J = 7.5 Hz, 1H, H-4), 13C NMR (75 MHz, CDCl3) δ 156.0 (NCO), 137.84 (Cq-Ar), 137.82 (Cq-Ar), 136.3 (C-1′), 128.52 (2 CH-Ar), 128.50 (2 CH-Ar), 128.0 (2 CH-Ar), 127.9 (4 CH-Ar), 116.4 (C-2′), 82.6 (C-2), 77.1 (C-1 or C-3), 72.4 (C-1 or C-3), 71.62 (CH2Ph), 71.57 (CH2Ph), 46.3 (C-4), HRMS (ESI) m/z 376.148 ([M + Na]+, calcd for C21H23NO4Na: 376.152).
R f 0.33 (EtOAc/petroleum ether, 1:1), [α]20D −9 (c 1.0, CHCl3), IR (film) 3374, 1728, 1220 cm−1, 1H NMR (400 MHz, CDCl3) δ 5.95 (ddd, J = 17.2, 10.4, 6.7 Hz, 1H, H-1′), 5.22 (d, J = 17.2 Hz, 1H, H-2′a), 5.15 (d, J = 10.4 Hz, 1H, H-2′b), 5.09 (t, J = 6.3 Hz, 1H, H-2), 4.99–4.86 (br s, 2H, NH2), 4.73 (m, 1H, H-1 or H-3), 4.68 (m, 1H, H-1 or H-3), 2.65 (q, J = 7.5 Hz, 1H, H-4), 2.06 (s, 6H, CH3), 13C NMR (100 MHz, CDCl3) δ 170.13 (CO), 170.10 (CO), 155.6 (NCO), 134.2 (C-1′), 117.3 (C-2′), 75.2 (C-2), 70.7 (C-1 or C-3), 69.9 (C-1 or C-3), 45.1 (C-4), 20.84 (CH3), 20.80 (CH3), HRMS (ESI) m/z 280.078 ([M + Na]+, calcd for C11H15NO6Na: 280.079).
R f 0.25 (silica gel, EtOAc/petroleum ether, 1:2), [α]20D +48 (c 1.0, CHCl3), IR (film) 3374, 1721, 1275 cm−1, 1H NMR (300 MHz, CDCl3) δ 8.07 (d, J = 8.1 Hz, 4H, Ph), 7.62–7.53 (m, 2H, Ph), 7.49–7.40 (m, 4H, Ph), 6.12 (ddd, J = 17.2, 10.5, 6.5 Hz, 1H, H-1′), 5.53 (t, J = 6.3 Hz, 1H, H-2), 5.34 (dt, J = 17.2, 1.7 Hz, 1H, H-2′a), 5.23 (dt, J = 10.4, 1.2 Hz, 1H, H-2′b), 5.16 (dd, J = 7.9, 6.3 Hz, 1H, H-1 or H-3), 4.96 (dd, J = 8.1, 6.3 Hz, 1H, H-1 or H-3), 4.76 (br s, 2H, NH2), 2.90 (q, J = 7.6 Hz, 1H, H-4), 13C NMR (75 MHz, CDCl3) δ 165.72 (CO), 165.67 (CO), 155.4 (NCO), 134.3 (C-1′), 133.5 (2 CH-Ar), 130.1 (3 CH-Ar), 130.0 (3 CH-Ar), 129.5 (Cq-Ar), 129.4 (Cq-Ar), 128.55 (CH-Ar), 128.54 (CH-Ar), 117.5 (C-2′), 75.6 (C-2), 71.0 (C-1 or C-3), 70.6 (C-1 or C-3), 45.8 (C-4), HRMS (ESI) m/z 404.109 ([M + Na]+, calcd for C21H19NO6Na: 404.110).
R f 0.19 (EtOAc/petroleum ether, 2:3), [α]20D +85 (c 1.0, CHCl3), IR (film) 1712, 1604, 1251, 1167, 1095 cm−1, 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 8.3 Hz, 4H, Ph), 6.95–6.87 (m, 4H, Ph), 6.11 (ddd, J = 17.1, 10.5, 6.5 Hz, 1H, H-1′), 5.49 (t, J = 6.3 Hz, 1H, H-2), 5.33 (d, J = 17.2 Hz, 1H, H-2′a), 5.22 (d, J = 10.4 Hz, 1H, H-2′b), 5.12 (m, 1H, H-1 or H-3), 4.93 (m, 1H, H-1 or H-3), 4.80 (br s, 2H, NH2), 3.86 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 2.85 (m, 1H, H-4), 13C NMR (100 MHz, CDCl3) δ 165.42 (Cq-OCH3 or CO), 165.36 (Cq-OCH3 or CO), 163.8 (2 Cq-OCH3 or CO), 155.5 (NCO), 134.4 (C-1′), 132.2 (2 CH-Ar), 132.1 (2 CH-Ar), 121.83 (Cq-Ar), 121.77 (Cq-Ar), 117.3 (C-2′), 113.80 (2 CH-Ar), 113.78 (2 CH-Ar), 75.3 (C-1 or C-2 or C-3), 71.1 (C-1 or C-2 or C-3), 70.3 (C-1 or C-2 or C-3), 55.59 (OCH3), 55.58 (OCH3), 45.9 (C-4), HRMS (ESI) m/z 464.130 ([M + Na]+, calcd for C23H23NO8Na: 464.132).
R f 0.46 (Et2O/CH2Cl2, 1:1), [α]20D +57 (c 1.0, CHCl3), IR (film) 3293, 1747, 1220 cm−1, 1H NMR (300 MHz, CDCl3) δ 6.03 (dd, J = 17.3, 10.6 Hz, 1H, H-1′), 5.99 (s, 1H, NH), 5.43 (d, J = 14.4 Hz, 1H, H-2′a), 5.38 (d, J = 7.6 Hz, 1H, H-2′b), 5.15 (dd, J = 5.8, 3.5 Hz, 1H, H-2), 5.08 (dd, J = 5.8, 1.7 Hz, 1H, H-1), 4.62 (dd, J = 3.5, 1.7 Hz, 1H, H-3), 2.14 (s, 3H, CH3), 2.12 (s, 3H, CH3), 13C NMR (75 MHz, CDCl3) δ 170.0 (CO), 169.4 (CO), 158.8 (NCO), 134.9 (C-1′), 118.1 (C-2′), 78.4 (C-3), 76.9 (C-2), 74.4 (C-1), 62.6 (C-4), 20.7 (CH3), 20.6 (CH3), HRMS (ESI) m/z 278.063 ([M + Na]+, calcd for C11H13NO6Na: 278.064).
R f 0.48 (EtOAc/toluene, 1:3), [α]20D +97 (c 1.0, CHCl3), IR (film) 3321, 1762, 1722, 1248 cm−1, 1H NMR (300 MHz, CDCl3) δ 8.12–8.04 (m, 4H, Ph), 7.65–7.56 (m, 2H, Ph), 7.51–7.43 (m, 4H, Ph), 6.20 (dd, J = 17.3, 10.7 Hz, 1H, H-1′), 5.96–5.90 (br s, 1H, NH), 5.54 (d, J = 17.3 Hz, 1H, H-2′a), 5.50–5.43 (m, 3H, H-1, H-2, H-2′b), 4.85 (dd, J = 2.8, 2.0 Hz, 1H, H-3), 13C NMR (75 MHz, CDCl3) δ 165.6 (CO), 165.2 (CO), 158.8 (NCO), 135.0 (C-1′), 134.0 (CH-Ar), 133.9 (CH-Ar), 130.2 (2 CH-Ar), 130.1 (2 CH-Ar), 128.82 (Cq-Ar), 128.78 (2 CH-Ar), 128.7 (2 CH-Ar), 128.6 (Cq-Ar), 118.2 (C-2′), 78.7 (C-3), 77.6 (C-1 or C-2), 75.1 (C-1 or C-2), 63.0 (C-4), HRMS (ESI) m/z 402.094 ([M + Na]+, calcd for C21H17NO7Na: 402.095).
R f 0.27 (EtOAc/toluene, 1:4), [α]20D = +144 (c 1.0, CHCl3), IR (film) 3326, 1761, 1716, 1605, 1250, 1168, 1100 cm−1, 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 6.7 Hz, 2H, Ph), 8.01 (d, J = 6.6 Hz, 2H, Ph), 6.93 (d, J = 6.6 Hz, 4H, Ph), 6.19 (dd, J = 17.3, 10.7 Hz, 1H, H-1′), 5.88 (br s, 1H, NH), 5.53 (d, J = 17.2 Hz, 1H, H-2′a), 5.47–5.38 (m, 3H, H-1 or H-3, H-2, H-2′b), 4.82 (dd, J = 3.1, 1.5 Hz, 1H, H-1 or H-3), 3.87 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 13C NMR (100 MHz, CDCl3) δ 165.3 (Cq-OCH3 or CO), 164.9 (Cq-OCH3 or CO), 164.2 (Cq-OCH3 or CO), 164.1 (Cq-OCH3 or CO), 158.8 (NCO), 135.2 (C-1′), 132.3 (2 CH-Ar), 132.2 (2 CH-Ar), 121.1 (Cq-Ar), 120.8 (Cq-Ar), 118.0 (C-2′), 114.04 (2 CH-Ar), 113.96 (2 CH-Ar), 78.8 (C-1 or C-2 or C-3), 77.4 (C-1 or C-2 or C-3), 75.0 (C-1 or C-2 or C-3), 63.0 (C-4), 55.65 (OCH3), 55.64 (OCH3), HRMS (ESI) m/z 462.110 ([M + Na]+, calcd for C23H21NO8Na: 462.116).
R f 0.65 (EtOAc/petroleum ether, 3:7), IR (film) 1748 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.40–7.30 (m, 2H, Ph), 7.35–7.15 (m, 3H, Ph), 6.01–5.85 (m, 1H, H-2′), 5.83 (dd, J = 17.3, 10.6 Hz, 1H, H-1′′), 5.34 (d, J = 10.6 Hz, 1H, H-2′′a), 5.31–5.15 (m, 3H, H-2′′b, H-3′), 4.84 (s, 1H, H-3), 4.07 (ddt, J = 15.5, 5.6, 1.4 Hz, 1H, H-1′a), 3.70 (dd, J = 15.4, 7.6, 1H, H-1′b), 2.82 (d, J = 12.9 Hz, 1H, H-1a) 2.47 (d, J = 13.0 Hz, 1H, H-1b), 1.49 (s, 3H, CH3), 13C NMR (100 MHz, CDCl3) δ 157.8 (NCO), 147.4 (Cq-Ar), 135.7 (C-1′′), 132.7 (C-2′), 127.9 (2 CH-Ar), 125.5 (CH-Ar), 124.3 (2 CH-Ar), 118.0 (C-3′ or C-2′′), 117.7 (C-3′ or C-2′′), 82.7 (C-3), 62.2 (C-4), 44.1 (C-2), 43.5 (C-1′), 39.1 (C-1), 25.3 (CH3), HRMSm/z 292.129 ([M + Na]+, calcd for C17H19NO2Na: 292.131).
R f 0.32 (EtOAc/petroleum ether, 1:4),IR (film), 1756, 1343, 1044, 703 cm−1, 1H NMR (300 MHz, CDCl3) δ 7.43–7.34 (m, 2H, Ph), 7.29–7.21 (m, 3H, Ph), 5.95 (dt, J = 6.1, 1.7 Hz, 1H, H-3′), 5.80 (dt, J = 6.0, 2.3 Hz, 1H, H-2′), 5.26 (s, 1H, H-3), 4.41 (dt, J = 16.0, 2.1 Hz, 1H, H-1′a), 3.99–3.88 (m, 1H, H-1′b), 2.64 (d, J = 13.0 Hz, 1H, H-1a) 2.45 (d, J = 13.0 Hz, 1H, H-1b), 1.50 (s, 3H, CH3), 13C NMR (100 MHz, CDCl3) δ 164.9 (NCO), 148.5 (Cq-Ar), 129.9 (C-3′), 129.7 (C-2′), 128.9 (2 CH-Ar), 126.5 (CH-Ar), 125.4 (2 CH-Ar), 86.5 (C-3), 74.3 (C-4), 54.6 (C-1′), 45.6 (C-2), 42.9 (C-1), 25.5 (CH3), HRMSm/z 264.096 ([M + Na]+, calcd for C15H15NO2Na: 264.099).
R f 0.17 (EtOAc/petroleum ether, 1:4), [α]20D +127 (c 1.0, CHCl3), IR (film) 1765, 1721, 1247, 1066 cm−1, 1H NMR (400 MHz, CDCl3) δ 8.08 (d, J = 7.2 Hz, 2H, Ph), 8.04 (d, J = 7.2 Hz, 2H, Ph), 7.64–7.56 (m, 2H, Ph), 7.51–7.42 (m, 4H, Ph), 6.17–6.09 (m, 2H, H-2′, H-3′), 5.61(dd, J = 6.2, 1.4 Hz, 1H, CH–O), 5.47 (dd, J = 6.1, 3.4 Hz, 1H, CH–O), 5.15 (dd, J = 3.2, 1.5 Hz, 1H, CH–O), 4.47 (d, J = 15.9 Hz, 1H, H-1′a), 3.85 (d, J = 16.2 Hz, 1H, H-1′b), 13C NMR (100 MHz, CDCl3) δ 165.5 (CO), 165.3 (CO), 163.4 (NCO), 133.9 (2 CH-Ar), 132.8 (C-2′ or C-3′), 130.11 (2 CH-Ar), 130.10 (2 CH-Ar), 128.9 (2 Cq-Ar), 128.74 (2 CH-Ar), 128.71 (2 CH-Ar), 126.8 (C-2′ or C-3′), 78.5 (CH–O), 77.9 (CH–O), 77.1 (C-4), 74.4 (CH–O), 55.7 (C-1), HRMS (ESI) m/z 414.093 ([M + Na]+, calcd for C22H17NO6Na: 414.095).
Footnotes |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c5ob02602d |
‡ Present address: SynCat, Université de Strasbourg/CNRS (UMR 7509), Ecole Européenne de Chimie, Polymères et Matériaux (ECPM), 25 rue Becquerel, 67087 Strasbourg, France. |
This journal is © The Royal Society of Chemistry 2016 |